Observed Signal · Sep 18, 2026 · Funding · Source: EU-Startups (European Venture) · Impact: 1/5 · Sentiment: Positive
Penelope Health Raises €87M for Payer Policy Platform
Penelope Health, a London-based provider of real-time provider and payer policy intelligence, has secured €87 million ($100 million) in funding. The investment was led by healthtech infrastructure platform Thoreau, with participation from existing backers Bertelsmann Healthcare Investments (BHI), Twine Ventures, and Seedcamp. The funding will be used to develop new products aimed at improving administrative efficiency in navigating payer requirements. Penelope's platform converts complex payer policy data into a single infrastructure layer, enabling healthcare companies to check coverage requirements, compare policies, and streamline operations. Currently, it covers policies for over 200 million Americans, spanning more than 15,000 procedures and drug codes. The company also announced a partnership with Thoreau to create a shared layer for real-time payments and clinical rules. This funding round highlights continued investment in European healthcare infrastructure and AI tools aimed at reducing administrative workloads.
Funding in healthcare tech, not directly related to AdTech/MarTech/AI advertising. The article does not focus on advertising or marketing technology, but on healthcare administrative efficiency. Not relevant to AdTech/MarTech/Advertising/AI industry.
Track Seedcamp Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Penelope Health secured €87 million ($100 million) in funding.
- Funding was provided by Thoreau, Bertelsmann Healthcare Investments (BHI), Twine Ventures, and Seedcamp.
- Penelope Health partners with Thoreau to create a shared layer for real-time payments and clinical rules.
- The platform covers policies for over 200 million Americans and more than 15,000 procedures and drug codes.
- Penelope Health was co-founded in 2025 by Dr. Sohum Patel and Mattijs De Paepe.
Connected Companies & Entities
1 Entity mapped“existing backers ... Seedcamp...”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
UK startup Pharosyn raises €2.5 million for pharma competitive intelligence platform
London-based Pharosyn, an AI-powered competitive intelligence platform for biopharma, has raised €2.5 million in a funding round led by Moonfire, with participation from Entrepreneurs First, Transpose Platform, and General Advance. The company plans to expand its platform and support wider adoption across pharmaceutical commercial and portfolio strategy teams. Founded in 2025 by Stephen Cowley and Joshua Hampson, Pharosyn monitors clinical, regulatory, and commercial data sources to produce strategic reports tailored to an organisation's pipeline. The funding is part of a broader trend of AI investment in pharma, with EU-Startups reporting approximately €75.3 million across seven comparable rounds this year.
Tandem Health Raises $100M Series B Led by EU Fund
Stockholm-based Tandem Health, a HealthTech startup developing an AI-native operating system for European clinics, has raised $100 million (€86.49 million) in Series B funding. The round was led by EQT's Scaleup Europe Fund, marking its first healthcare investment, with participation from existing investors Kinnevik, Northzone, Amino Collective, and Visionaries. Tandem's AI co-pilot assists clinicians by generating medical notes, preparing patient summaries, aiding clinical decisions, and automating documentation; it is certified as a Class IIa medical device under EU regulations. Used by over 10,000 care organizations across 14 European markets, including the NHS, Ramsay Santé, and Humanitas, the company has now raised a total of $160 million following a $50 million Series A last year. The funding will support European expansion, growth of its clinician-led team, and the evolution into a comprehensive AI-native clinic operating system.
Health AI Startup Heidi Raises $340M at $900M Valuation
Australian health AI startup Heidi has closed a Series C round of $100 million, led by Blackbird, with participation from Phoenix Court, Point72 Private Investments, and Headline, valuing the company at $900 million. In parallel, Heidi secured $240 million in growth financing from General Catalyst's Customer Value Fund, a revenue-based instrument that covers sales and customer acquisition costs. Combined, these deals provide $340 million in fresh capital. The company has raised $436.6 million to date. Heidi, founded in Melbourne, started as an AI scribe for clinical documentation and now positions itself as an 'AI care partner'. It reports 2.8 million patient encounters per week across 190 countries. The funding will support regulatory work for advanced clinical features in Europe and the UK, and expansion in the DACH region.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.